Discusses AI Solutions, Product Advancements, and Strategic Opportunities in Data Transformation July 7, 2026 3:00 PM ...
Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy July 7, 2026 4:30 PM EDTCompany ParticipantsSean Grant ...
Scientists and advocates worry the state’s predator control gamble will fail but still expand aerial bear gunning across ...
Natural Gas Industry Decision-Makers Gather at this Annual Forum to Consider Insights into U.S. Rockies and West Natural Gas ...
TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Morning Overview on MSN
Ozempic helped adults over 65 shed more than 15% of their body weight in a new study
Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...
Trust Stamp (Nasdaq: IDAI), today announced that its Maltese subsidiary, Trust Stamp Malta Limited, has been selected as a ...
Developers are increasingly relying on large language models (LLMs) for everyday computing tasks such as fixing bugs, ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Patients with difficult to manage or treatment-refractory axial spondyloarthritis may benefit from a tailored therapeutic approach.
The inaugural season of the Gomezgil Yaspik Data Science Laboratory marks the beginning of a new chapter for for Bowdoin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results